Language selection

Search

Details for: NEUPOGEN

Company: AMGEN CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
01968017NEUPOGENFILGRASTIM300 MCG / MLSOLUTIONINTRAVENOUS
01968017NEUPOGENFILGRASTIM300 MCG / MLSOLUTIONSUBCUTANEOUS
02420104NEUPOGENFILGRASTIM600 MCG / MLSOLUTIONINTRAVENOUS
02420112NEUPOGENFILGRASTIM600 MCG / MLSOLUTIONINTRAVENOUS
02420104NEUPOGENFILGRASTIM600 MCG / MLSOLUTIONSUBCUTANEOUS
02420112NEUPOGENFILGRASTIM600 MCG / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: